A Randomized, Open Label, Active-controlled, Multiple Dosing and Crossover Clinical Trial to Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of YH4808 after Postprandial Oral Administration in Healthy Volunteers

Trial Profile

A Randomized, Open Label, Active-controlled, Multiple Dosing and Crossover Clinical Trial to Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of YH4808 after Postprandial Oral Administration in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 31 May 2017

At a glance

  • Drugs YH 4808 (Primary) ; Esomeprazole
  • Indications Gastro-oesophageal reflux; Peptic ulcer
  • Focus Pharmacokinetics
  • Sponsors Yuhan
  • Most Recent Events

    • 14 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Mar 2013 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea: KCT0000695).
    • 23 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top